IGI Laboratories To Present At 27th Annual ROTH Capital Conference On March 9, 2015
BUENA, N.J., March 9, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting today at the 27th Annual ROTH Conference. The Conference will take place on March 8-11, 2015 at the Ritz-Carlton, Laguna Niguel, Dana Point, California.
Jason Grenfell-Gardner, CEO and President and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Monday, March 9, 2015 at 10:30 a.m. PT / 1:30 p.m. ET.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.igilabs.com. A replay will be available for 90 days.
About IGI Laboratories, Inc. IGI Laboratories is a specialty generic drug development and manufacturing company. Our mission is to be a leading player in the specialty generic prescription drug market.
Logo - http://photos.prnewswire.com/prnh/20130827/MM70487LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/igi-laboratories-to-present-at-27th-annual-roth-capital-conference-on-march-9-2015-300047343.html
SOURCE IGI Laboratories, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
- Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors
- abrdn Asia-Pacific Income Fund VCC Announces Pricing of 2024 Voluntary Cash Redemption
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!